Chengqian Zhang

The paper identifies small-molecule inhibitors of the bacterial CBASS defense system to enhance phage therapy by blocking Cap5 activity.

The paper identifies small molecule inhibitors of the Thoeris antiphage immune system in bacteria, showing that persistent immunity is required to prevent phage revival and population collapse.

This study identifies chemical inhibitors that block a bacterial immune system, enhancing phage therapy efficacy against resistant strains.

The paper identifies a bacterial secondary metabolite that sensitizes competitors to phage infection, providing a fitness advantage to the producer.